Choate Investment Advisors Laboratory Corp Of America Holdings Transaction History

Choate Investment Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$192.5 - $216.35 $45,237 - $50,842	235 Added 18.8%	1,485 $302,000
Q1 2024 May 07, 2024	SELL	$209.01 - $232.56 $418 - $465	-2 Reduced 0.16%	1,250 $273,000
Q4 2023 Feb 14, 2024	BUY	$197.69 - $227.29 $20,559 - $23,638	104 Added 9.06%	1,252 $284,000
Q3 2023 Oct 30, 2023	BUY	$201.05 - $221.7 $230,805 - $254,511	1,148 New	1,148 $230,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Choate Investment Advisors with notifications on news.